A High Risk/High Reward Way To Play The Shift To Biotech Solutions
When it comes to treating diseases, the author of today’s article notes “It seems that there is a shift away from treating symptoms with chemical…
stock market
A New Multi-Bagger Opportunity In The Electric Vehicle Space
For those who missed out on the massive rallies of Tesla and other electric vehicle companies, today’s article highlights another potential multi-bagger opportunity in the…
The Approval Of An Oregon Ballot Measure Could Make This Biotech Startup An Under-The-Radar Election Winner
Amid all the high drama surrounding last week’s elections, a smaller development could have big implications for one biotech startup. As today’s article explains, voters…
More Outperformance Ahead For These 2 “Class of 2018” Biotech Stocks?
The two biotech stocks highlighted in today’s article both made their public market debuts in 2018 – and both have performed very well for investors…
These 5 Drug/Biotech Stocks Have The Combination To Unlock An Earnings Surprise
Amid a third-quarter earnings season that has been a mixed bag of beats and misses for drug/biotech companies, today’s article highlights five drug/biotech stocks that…
This Biotech Stock Could Be A Good “Bad News Buy”
When it comes to the biotech stock that’s the focus of today’s article, which plummeted in mid-October when the company abruptly pulled the plug on…
These Biotechs Are Awaiting FDA Rulings In November
October has seen the FDA approve the first drug for COVID-19 (remdesivir), the first treatment for Ebola virus (Regeneron Pharmaceuticals’ Inmazeb), and the first drug…
This Biotech Stock Has High Return Potential – And A Potential Bump In The Road
The biotech company highlighted in today’s article, specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, is one that…
Biggest Biotech Bargains
“Although the vast majority of biotech stocks are losing money, a handful of these profitable drug developers are valued at levels that make them absolute…
The Best Play For Biotech’s Breakout May Not Be The Obvious Play
“Biotech stocks are breaking out,” declares the author of today’s article. When it comes to playing this breakout, however, he advises that the obvious play…